Does Mounjaro Really Work?

June 25, 2023

Mounjaro—the brand name for the drug tirzepatide—is marketed as an effective weight loss medication. But does it actually work? Let’s look at the facts.

Does Mounjaro really work?

Taking weekly injections of Mounjaro curbs appetite, helping patients stick to a reduced-calorie diet. It does this by keeping food in the stomach longer and by slowing down production of a hormone that increases appetite.

One study published in the New England Journal of Medicine in July of 2022 showed that patients injecting 15.0 mg of Mounjaro for 72 weeks lost almost 21% of body weight on average. This makes it the most effective weight loss medication available. The only weight loss strategy more effective would be surgery, which is significantly more costly and dangerous.

How is Mounjaro taken?

Mounjaro is injected under the skin by the patient on a weekly basis. Doses begin at 2.5 mg and can be raised to 5.0 mg, 10.0 mg, or 15.0 mg.

What are the typical side effects?

Side effects are usually mild, including slight nausea and stomach upset.

How much does Mounjaro cost?

The price of tirzepatide is around $1,000 for a carton of 4 doses (a one month supply of 2.5 mg syringes). To see prices in your area, visit the GoodRX Mounjaro page.

How can I get a prescription for Mounjaro?

This medication is available with a prescription from a physician or other licensed prescriber. QuickMD is able to prescribe Mounjaro online via telemedicine, if clinically appropriate. Talk to a QuickMD provider to see if Mounjaro is a good option for you.

Articles on this website are meant for educational purposes only and are not intended to replace professional medical advice, diagnosis or treatment. Do not delay care because of the content on this site. If you think you are experiencing a medical emergency, please call your doctor immediately or call 911 (if within the United States).

This blog and its content are the intellectual property of QuickMD LLC and may not be copied or used without permission.